Difficulty: Medium
Average Score: 85%
Practice
A 54-year-old man with seizure disorder and chronic neuropathic pain presents to his primary care physician for follow-up. Review of his laboratory studies indicates elevated liver function tests to four times the normal levels. Which of the following agents would be preferred to manage this patient?
Correct answer
D
Rationale
In this scenario, the preferred agent to manage the 54-year-old man with elevated liver function tests due to his seizure disorder and chronic neuropathic pain would be option D) Pregabalin.
Pregabalin is preferred in this case because it is primarily excreted unchanged by the kidneys, making it suitable for patients with hepatic impairment as it does not rely on liver metabolism for its elimination. This reduces the risk of drug accumulation and toxicity in patients with liver dysfunction.
Regarding why the other options are not preferred:
A) Carbamazepine, B) Phenobarbital, and C) Phenytoin are metabolized in the liver, and their use can be problematic in patients with elevated liver function tests as they may exacerbate liver damage or lead to drug accumulation due to impaired metabolism and clearance.
From an educational perspective, this case highlights the importance of considering a patient's comorbidities, such as liver dysfunction, when selecting pharmacological treatments. It underscores the need for healthcare providers to have a comprehensive understanding of drug pharmacokinetics and the impact of organ dysfunction on drug metabolism to make safe and effective treatment decisions.
Pregabalin is preferred in this case because it is primarily excreted unchanged by the kidneys, making it suitable for patients with hepatic impairment as it does not rely on liver metabolism for its elimination. This reduces the risk of drug accumulation and toxicity in patients with liver dysfunction.
Regarding why the other options are not preferred:
A) Carbamazepine, B) Phenobarbital, and C) Phenytoin are metabolized in the liver, and their use can be problematic in patients with elevated liver function tests as they may exacerbate liver damage or lead to drug accumulation due to impaired metabolism and clearance.
From an educational perspective, this case highlights the importance of considering a patient's comorbidities, such as liver dysfunction, when selecting pharmacological treatments. It underscores the need for healthcare providers to have a comprehensive understanding of drug pharmacokinetics and the impact of organ dysfunction on drug metabolism to make safe and effective treatment decisions.